Core Insights - VCI Energy Sdn Bhd is expanding into infrastructure-scale energy by partnering with DPS Energy to develop a utility-scale solar photovoltaic platform of up to 250 megawatts in Malaysia, with a project value estimated between US$200 to 300 million and potential long-term contracted revenue of US$360 to 480 million [1][4]. Group 1: Project Overview - The project will support the growing demand for data center power driven by AI and cloud workloads, with an estimated annual generation of approximately 350 to 450 gigawatt-hours (GWh) [2][3]. - The solar platform is designed to facilitate long-term power purchase agreements with utilities and data center operators, while also being prepared for future battery energy storage integration [2][4]. Group 2: Financial Projections - At full scale, the project is expected to generate an annual gross revenue of US$18 to 24 million, with cumulative contracted revenue projected at US$360 to 480 million over a 20-year operating life [4]. - The valuation of utility-grade solar assets is estimated at approximately US$0.8 to 1.2 million per megawatt, indicating a significant gross project value upon completion [3][4]. Group 3: Strategic Alignment - The initiative aligns with Malaysia's goals to increase renewable energy capacity to 31% by 2025 and 40% by 2035, positioning VCI Global as a key player in supporting the country's digital economy and renewable energy infrastructure [5][6]. - The project is seen as a critical step in enhancing access to reliable renewable power, which is essential for the expansion of AI and hyperscale data centers in Malaysia [6][5].

Core Insights - HII's Ingalls Shipbuilding division has been awarded a contract by the U.S. Navy to design and build the future small surface combatant (SSC) ship, utilizing the design of the proven Legend-class national security cutter (NSC) [1] - The Ingalls team is currently engaged in building three classes of ships and modernizing Zumwalt-class destroyers, demonstrating their capacity and expertise in shipbuilding [2] - HII has invested over $1 billion in infrastructure and partnerships to enhance shipbuilding capabilities and explore the addition of a new shipyard in the U.S. [3] Company Overview - HII is recognized as the largest military shipbuilder in the U.S., with a history of over 135 years in advancing national security [5] - The company employs a workforce of 44,000 and provides a range of capabilities from ships to unmanned systems and advanced technologies [5] - HII's mission focuses on delivering powerful ships and solutions to support national defense and global peace [4]

Core Insights - Outlook Therapeutics reported a net loss of $62.4 million for fiscal year 2025, an improvement from a net loss of $75.4 million in the previous year, with revenue of $1.4 million compared to no revenue in fiscal 2024 [2][17] - The company has initiated sales of LYTENAVA™ in Germany and the UK, with a positive trend in the number of accounts ordering the product and the breadth of prescribing clinicians [3][12] - The company is preparing for potential FDA approval of ONS-5010, with a goal date set for December 31, 2025 [7][8] Financial Performance - For the fiscal year ended September 30, 2025, Outlook Therapeutics reported a gross profit of $57,000, with total revenues of $1.4 million [2][17] - Operating expenses decreased by $4.6 million compared to fiscal 2024, primarily due to reduced R&D expenses following the completion of the NORSE Eight clinical trial [4][17] - As of September 30, 2025, the company had cash and cash equivalents of $8.1 million, not including $14.9 million from recent sales under its at-the-market offering program [5][19] Market and Product Development - LYTENAVA™ has been accepted into the tender framework in the UK, which is expected to enhance unit sales [3] - The company is actively pursuing commercial launch activities in the U.S. and expanding into additional European markets, including Austria and the Netherlands [6][12] - ONS-5010/LYTENAVA™ is an investigational product in the U.S. and requires pricing and reimbursement approval in certain EU member states before it can be sold [9][13]

ORLANDO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced its plans to transfer the listing of its [Class A] common stock to the New York Stock Exchange (“NYSE”) from the Nasdaq Stock Market LLC (“Nasdaq”). Abacus expects to begin trading as a NYSE listed company on or about December 30, 2025, and will commence trading under new ticker symbol “ABX”. The Company’s [Class A] com ...

Company announcement no. 57 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 45 14 14 00 19 December 2025 Page 1 Lars-Erik Brenøe steps down from Danske Bank’s Board of Directors As communicated on 21 February 2025 in the notice convening the annual general meeting, Lars-Erik Brenøe will step down from the Board of Directors of Danske Bank A/S at the end of this year. After almost a decade of service, Lars-Erik Brenøe has notified the Board of his decision to step down, effective at 31 Dece ...

CAMBRIDGE, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that its development partner, GSK, filed a New Drug Application (NDA) resubmission to the U.S. Food and Drug Administration (FDA) for tebipenem HBr, an investigational oral carbapenem antibiotic being developed for the treatment of co ...

LONG BEACH, Calif. and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., applauds yesterday’s cannabis reform action from the Trump administration. “The executive order to reschedule cannabis to a Schedule III classification and the authorization of a pilot program for Medicare reimbursement of the cannabis ...

Total national coverage footprint for PENFS increases to roughly 100 million covered livesCARMEL, Ind., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced significant new medical policy coverage from a major national health insurer for Percutaneous Electrical Nerve Field Stimulation (“PENFS”). The coverage sp ...

LONDON, Ontario, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the pricing of its underwritten U.S. public offering (the “Offering”) of 1,739,130 common shares, together with accompanying warrants to purchase 869,565 common sha ...

VEON’s Mobilink Microfinance Bank Launches Islamic Banking Operations in Pakistan A new era of digital Islamic finance Dubai and Islamabad, December 19, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, announced today that its financial services subsidiary, Mobilink Microfinance Bank Ltd., has launched Islamic banking operations in Pakistan, expanding access to Shariah-compliant financial services in in response to growing customer demand. Mobilink Bank inaugurated its first dedicated Islami ...